Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel N2-glycosyl triazole synthesis offers high yield and alpha-glucosidase inhibition for diabetes drug development and supply chain optimization.
Novel epoxy ethyl methanol route for Lacosamide. High purity, scalable process. Reliable pharmaceutical intermediates supplier for global supply chains.
Patent CN107573333B reveals a novel Ticagrelor intermediate synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102119165A introduces stable chiral iridium catalysts for asymmetric transfer hydrogenation in water, offering safer and greener pharmaceutical intermediate manufacturing.
Novel aqueous chiral iridium catalyst enables safe, high-yield asymmetric transfer hydrogenation for pharmaceutical intermediates with superior stability.
Patent CN110028457B reveals a high-yield, three-step synthesis for isotope-labeled sulfadimidine, offering superior purity for veterinary drug analysis and supply chain stability.
Novel synthesis route for cardiovascular intermediate. Optimized oxidation and cyanation steps ensure high purity and scalable production for global supply chains.
Patent CN104945299A offers improved Vildagliptin synthesis. Homogeneous phase reaction enhances purity and simplifies supply chain for pharmaceutical intermediates.
Discover the safe, green synthesis of 1-tetrazole acetate via patent CN111393382A. Eliminate sodium azide risks and ensure high-purity supply for cephalosporin manufacturing.
Patent CN110550992A reveals green photocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105367477A details a safer 1-Methyltryptophan synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Novel purification method ensures pharmaceutical grade quality while eliminating genotoxic reagents for reliable supply chain.
Novel two-step silodosin preparation method offers high yield and scalable production for reliable API supply chain optimization and significant cost efficiency in pharmaceutical manufacturing.
Patent CN102414200B reveals aqueous solvent method reducing impurities. Offers cost reduction and supply reliability for hypertension drug manufacturing.
Patent CN107287256A details a novel whole-cell catalytic method for L-2-piperidinecarboxylic acid, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN112588319A reveals a novel silane-catalyzed route for TUDCA synthesis, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN101811978B enables high-yield production of pharmaceutical intermediates with mild conditions and reduced supply chain complexity for global buyers.
Novel aqueous solvent method reduces impurities in Olmesartan Medoxomil synthesis ensuring supply chain reliability and cost effective pharmaceutical intermediates manufacturing.
Patent CN111100172B reveals a mild Lewis acid catalyzed route for high-purity capecitabine intermediates, offering significant cost and supply chain advantages.
Patent CN118772160A reveals a visible-light photocatalytic synthesis for trifluoromethyl dihydropyrroloquinazolinones, offering cost reduction and supply chain reliability for pharmaceutical intermediates.